Key Legislative Changes in the Pharmaceutical and Healthcare Sectors in 2025
Experts at REVERA Law Group have prepared a practical overview of the key changes that shaped the development of the pharmaceutical industry in 2025 in Belarus, the EAEU member states, as well as in Georgia and Kazakhstan.
The material is practical in nature and business-oriented: it provides a structured analysis of the key regulatory developments, current requirements, and emerging trends that market participants are already facing. Particular attention is given to the harmonisation of rules within the EAEU, changes in the procedures for the registration of medicinal products and medical devices, as well as the development of approaches in the areas of GLP, GCP, and the use of real-world clinical data.
Inside the overview:
The material covers changes in the regulation of medicinal products and medical devices in the following areas:
- registration
- clinical trials
- pricing
- public procurement
- and others
| What to watch for: key legal, regulatory, contractual, employment, tax, and communications issues in the Life Sciences sector |
The overview is based on the expertise of specialists with extensive experience in supporting projects across various jurisdictions, which makes it possible to assess the ongoing changes comprehensively and evaluate their impact on companies’ business processes.
The document will help pharmaceutical and medical companies adapt to new requirements in a timely manner, build appropriate regulatory strategies, and minimise legal risks.
Material and overview authors: Andrey Artyushenko, Sergey Suschenya, Melano Svanidze, Iryna Navitskaya, Oksana Iashagyan, Alibek Slan, Denis Valukevich.
Download the full overview to learn more about the key trends and the practical aspects of these changes.
Download the overview file
